RxSight, Inc. to Present at the Needham Healthcare Conference
On April 5, 2023, RxSight, operating under the stock symbol RXST, announced its participation in the Needham Healthcare Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
On April 5, 2023, RxSight, operating under the stock symbol RXST, announced its participation in the Needham Healthcare Conference. The management team will engage in a fireside chat on April 19, 2023, at 11:15 a.m. PT, accessible via a live and archived webcast on their investor relations website.
RxSight is an ophthalmic medical device company focused on enhancing vision after cataract surgery with its innovative RxSight Light Adjustable Lens system. This technology allows for custom adjustments post-surgery, providing patients with optimized visual outcomes. For more details, visit www.rxsight.com.
Details
News Market Reaction – RXST
The recorded move for RXST in the trading session of this news was +3.12%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALISO VIEJO, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Needham Healthcare Conference.
RxSight’s management is scheduled to participate in a fireside chat on Wednesday, April 19, 2023, at 11:15 a.m. Pacific Time / 2:15 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery enabling doctors to customize and deliver high-quality of vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Company Contact:
Shelley Thunen
RxSight, Inc.
949-521-7830
sthunen@rxsight.com
Investor Relations Contact:
ir@rxsight.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.